ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,822 | -72.2% | 1,479 | -68.0% | 0.01% | -78.1% |
| Q2 2023 | $110,769 | +20.3% | 4,625 | -20.0% | 0.03% | +3.2% |
| Q4 2022 | $92,081 | +18.1% | 5,784 | +4.2% | 0.03% | -35.4% |
| Q2 2022 | $78,000 | -74.3% | 5,550 | -55.7% | 0.05% | -68.6% |
| Q1 2022 | $304,000 | +12.2% | 12,517 | +8.0% | 0.15% | +21.4% |
| Q4 2021 | $271,000 | +71.5% | 11,589 | +21.8% | 0.13% | +23.5% |
| Q3 2021 | $158,000 | -33.9% | 9,518 | -2.8% | 0.10% | -32.0% |
| Q2 2021 | $239,000 | +455.8% | 9,793 | +492.1% | 0.15% | +111.3% |
| Q1 2021 | $43,000 | – | 1,654 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |